Yuma Therapeutics Corporation

Cambridge, MA Yukari Perrella

UEI
VVJCSERSEAA6
CAGE
5MAS7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
10 Linnaean St, Cambridge, MA 02138, USA
Website
yumatherapeutics.com
Founded
2009
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Research & Consulting Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
CSF TAU biomarker-guided development of HSP90 inhibitors for alzheimer's disease R41AG042205 National Institutes of Health $200,752
Brain penetrant HSP90 inhibitors for alzheimer's disease R42AG042205 National Institutes of Health $1,473,584

Quick answers

Is Yuma Therapeutics Corporation registered in SAM.gov?

Yes. Yuma Therapeutics Corporation's SAM.gov registration is active through August 3, 2027.

What is Yuma Therapeutics Corporation's most recent federal award?

Yuma Therapeutics Corporation's most recent federal grant award is CSF TAU biomarker-guided development of HSP90 inhibitors for alzheimer's disease (R41AG042205), from National Institutes of Health, on September 1, 2012.

On GovTribe

See Yuma Therapeutics Corporation's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login